Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 31, Issue 3, 2011, Pages 137-145

  Lavie, Carl J ^a   Church, Timothy S ^b   Milani, Richard V ^a   Earnest, Conrad P ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

C reactive protein; Coronary disease; Exercise training; Heart failure; Inflammation

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

CARDIOPULMONARY FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EXERCISE; FOLLOW UP; HEART FAILURE; HEART REHABILITATION; HUMAN; INFLAMMATION; OBESITY; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; EXERCISE THERAPY; HUMANS; INFLAMMATION; MOTOR ACTIVITY; PHYSICAL FITNESS; PLAQUE, ATHEROSCLEROTIC; PREVENTIVE HEALTH SERVICES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; WEIGHT LOSS;

EID: 79959837992     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e3182122827     Document Type: Review

References (63)

1. Libby P, Ridker PM, Hansson GK;for the Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-2138.
2. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519. (Pubitemid 43980523)
3. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610-621. (Pubitemid 43209108)
4. Musunuru K, Kral BG, Blumenthal RS. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5:621-635.
5. Lavie CJ, Milani RV, Verma A, O'Keefe JH. C-reactive protein and cardiovascular diseases-is it ready for primitive? Am J Med Sci. 2009;338:486-492.
6. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med. 2007;167:31-39. (Pubitemid 46072404)
7. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
8. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-1158. (Pubitemid 28548534)
9. Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell. 1995;80:15-18.
10. Yu Z, Ye X, Wang J, et al. Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older Chinese people. Circulation. 2009;119:2969-2977.
11. Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc. 2009;84:373-383.
12. Lavie CJ, Milani RV. Effects of nonpharmacologic therapy with cardiac rehabilitation and exercise training in patients with low levels of high-density lipoprotein cholesterol. Am J Cardiol. 1996;78:1286-1289. (Pubitemid 126657210)
13. Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J. 2002;143:349-355.
14. Geffken DF, Cushman M, Burke GL, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153:242-250. (Pubitemid 32958648)
15. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002;13:561-568.
16. Mora S, Lee IM, Buring JE. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA. 2006;295:1412-1419.
17. LaMonte MJ, Durstine JL, Yanowitz FG, et al. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation. 2002;106:403-406. (Pubitemid 34803681)
18. Okita K, Nishijima H, Murakami T, et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol. 2004;24:1868-1873. (Pubitemid 39350305)
19. Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J. 2005;26:2018-2025. (Pubitemid 41435729)
20. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397. (Pubitemid 38419992)
21. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29-38. (Pubitemid 40075678)
22. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352: 20-28. (Pubitemid 40075677)
23. Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation. 2006;114:281-288. (Pubitemid 44297094)
24. Ridker PM, Danielson E, Fonesca FA, et al;JUPITER Trial Study Group. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009;373:1175-1182.
25. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on low density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol. 1994;74:1192-1195. (Pubitemid 24375006)
26. Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA. The importance of recognizing and treating low levels of highdensity lipoprotein cholesterol: a new era in atherosclerosis management. Rev Cardiovasc Med. 2008;9:239-258.
27. Lavie CJ, Milani RV. Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era. J Am Coll Cardiol. 2008;51:56-58.
28. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483-1402.
29. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925-1932.
30. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120:799-806. (Pubitemid 47313351)
31. Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol. 2004;93:336-339. (Pubitemid 38167432)
32. Lavie CJ, Milani RV. Prevalence of hostility in young coronary artery disease patients and effects of cardiac rehabilitation and exercise training. Mayo Clin Proc. 2005;80:335-342. (Pubitemid 40316295)
33. Lavie CJ, Milani RV. Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med. 2006;166:1878-1883. (Pubitemid 44455171)
34. Milani RV, Lavie CJ. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med. 2009;122:931-938.
35. Albert MA, Glynn RJ, Rikder PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2009;93:221-225.
36. Pischon T, Hankinson SE, Hotamisligil GS, et al. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11:1055-1064. (Pubitemid 41151582)
37. Manns PJ, Williams DP, Snow CM, Wander RC. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement. Am J Hum Biol. 2003;15:91-100. (Pubitemid 36124129)
38. Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA. Plasma Creactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol. 2004;96:143-148. (Pubitemid 38031994)
39. Valentine RJ, Vieira VJ, Woods JA, Evans EM. Stronger relationship between central adiposity and C-reactive protein in older women than men. Menopause. 2009;16:84-89.
40. Giallauria F, Palomba S, De Sio I, et al. Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2009;70:394-400.
41. McGavock JM, Mandic S, Vonder Muhil I, et al. Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes. Diabetes Care. 2004;27:320-325. (Pubitemid 38174051)
42. Obisesan TO, Leeuwenburgh C, Phillips T, et al. C-reactive protein genotypes affect baseline, but not exercise traininginduced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol. 2004;24:1874-1879. (Pubitemid 39350306)
43. Huffman KM, Samsa GP, Slentz CA, et al. Response of highsensitivity C-reactive protein to exercise training in an at-risk population. Am Heart J. 2006;152:793-800. (Pubitemid 44396887)
44. Stewart LK, Earnest CP, Blair SN, Church TS. Effects of different doses of physical activity on C-reactive protein among women. Med Sci Sports Exerc. 2010;42:701-707.
45. Church TS, Earnest CP, Thompson AM, et al. Exercise without weight loss does not reduce C-reactive protein: the INFLAME Study. Med Sci Sports Exerc. 2010;42:708-716.
46. Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes in Creactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndrome. Metabolism. 2010;59:54-61.
47. Campbell KL, Campbell PT, Ulrich CM, et al. No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev. 2008;17:1714-1718.
48. Campbell PT, Campbell KL, Wener MH, et al. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc. 2009;41:1533-1539.
49. Olson TP, Dengel DR, Leon AS, Schmitz KH. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond). 2007;31:996-1003. (Pubitemid 46842686)
50. Kelley GA, Kelley KS. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism. 2006;55:1500-1507. (Pubitemid 44540369)
51. Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 2004;43:1056-1061.
52. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol. 2003;92:50-54.
53. Lavie CJ, Morshedi-Meibodi A, Milani RV. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr. 2008;3:136-140.
54. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med. 2009;122:1106-1114.
55. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in Creactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005;25:332-336;quiz 337-338.
56. Ades PA, Savage PD, Toth MJ, et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation. 2009;119:2671-2678.
57. Lecour S, James R. When are pro-inflammatory cytokines SAFE in heart failure? [published online ahead of print February 7, 2011]. Eur Heart J.
58. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol. 2005;95:17C-23C. (Pubitemid 40755514)
59. Davies EJ, Moxham T, Rees K, et al. Exercise training for systolic heart failure: Cochrane systematic review and metaanalysis. Eur J Heart Fail. 12:706-715.
60. Flynn KE, Pina IL, Whellan DJ;for the HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451-1459.
61. Conraads VM, Beckers P, Bosmans J, et al. Combined endurance/resistance training reduces plasma TNF-α receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J. 2002;23:1854-1860. (Pubitemid 35398054)
62. Guasch E, Benito B, Nattel S. Exercise training, inflammation and heart failure: working out to cool down. J Physiol. 2010;588(pt 14):14:2525-2526.
63. Nunes RB, Tonetto M, Machado N, et al. Physical exercise improves plasmatic levels of IL-10, left ventricular end-diastolic pressure, and muscle lipid peroxidation in chronic heart failure rats. J Appl Physiol. 2008;104:1641-1647.